PEN Penumbra, Inc.
Healthcare$328.20-0.15%ClosedMarket Cap: $12.91B
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$369.83
Target (Median)
$374.00
Target Range
$335.00 - $388.00
Upside from current price: 12.7%
Rating Distribution
2 Strong Buy2 Buy13 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | Citigroup | maintain | Neutral | Neutral |
| 2026-05-07 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-02-26 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-01-20 | RBC Capital | downgrade | Sector Perform | Outperform |
| 2026-01-20 | Canaccord Genuity | downgrade | Hold | Buy |
| 2026-01-16 | BTIG | downgrade | Neutral | Buy |
| 2026-01-16 | Citigroup | downgrade | Neutral | Buy |
| 2026-01-16 | Leerink Partners | downgrade | Market Perform | Outperform |
| 2026-01-16 | Jefferies | downgrade | Hold | Buy |
| 2026-01-16 | Truist Securities | downgrade | Hold | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $4.91 | $1.59B | 6 |
| Fri Dec 31 | $6.05 | $1.80B | 9 |
| Sun Dec 31 | $7.30 | $2.05B | 4 |
| Mon Dec 31 | $8.42 | $2.33B | 2 |